ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System

Running, not enrolling · Not applicable · Has a placebo group

Conditions studied: Heart Failure

In brief

This is a prospective, multi-center, randomized, sham-controlled, double-blinded (participant and outcomes assessor) clinical trial.

Key facts

Study ID
NCT05686317
Run by
Edwards Lifesciences
People needed
100
Starts
2023-04-01
Expected to finish
2030-08-31
Last updated by the study team
2026-06-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.